Invention Grant
- Patent Title: Galactoside inhibitor of galectins
-
Application No.: US15535829Application Date: 2016-01-28
-
Publication No.: US10774102B2Publication Date: 2020-09-15
- Inventor: Thomas Brimert , Richard Johnsson , Hakon Leffler , Ulf Nilsson , Fredrik Zetterberg
- Applicant: Galecto Biotech AB
- Applicant Address: DK Copenhagen
- Assignee: Galecto Biotech AB
- Current Assignee: Galecto Biotech AB
- Current Assignee Address: DK Copenhagen
- Agency: Maier & Maier, PLLC
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@c30e8af com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@240a1747
- International Application: PCT/EP2016/051836 WO 20160128
- International Announcement: WO2016/120403 WO 20160804
- Main IPC: C07H17/02
- IPC: C07H17/02 ; C07H19/056 ; C07H15/203 ; C07H13/10 ; C07H13/08 ; C07H15/26 ; C07H15/207
Abstract:
An embodiment of the present invention relates to a compound of the general formula. The compound of formula is suitable for use in a method for treating a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human. Furthermore an embodiment of the present invention concerns a method for treatment of a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human.
Public/Granted literature
- US20170349619A1 ALPHA-D-GALACTOSIDE INHIBITORS OF GALECTINS Public/Granted day:2017-12-07
Information query
